Recombinant Human FOXC1 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P12060; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human FOXC1 Protein is a type of protein that is produced in a laboratory using recombinant DNA technology. This protein belongs to the forkhead box (FOX) family of transcription factors, which are proteins that play a crucial role in the regulation of gene expression. FOXC1 is a transcription factor that is involved in various cellular processes, including embryonic development, cell differentiation, and tissue homeostasis.
Recombinant Human FOXC1 Protein is a 553 amino acid protein with a molecular weight of approximately 60 kDa. It contains a highly conserved DNA-binding domain known as the forkhead domain, which is essential for its transcriptional activity. This domain consists of three alpha-helices and two beta-strands, which form a winged-helix structure that allows FOXC1 to bind to specific DNA sequences.
In addition to the forkhead domain, Recombinant Human FOXC1 Protein also has a C-terminal transactivation domain, which is responsible for activating the transcription of target genes. This domain contains several conserved amino acid motifs, including the LXXLL motif, which interacts with other transcriptional co-regulators to enhance FOXC1’s transcriptional activity.
Recombinant Human FOXC1 Protein plays a critical role in regulating gene expression by binding to specific DNA sequences and activating or repressing the transcription of target genes. It has been shown to interact with various transcriptional co-regulators, such as histone deacetylases and histone acetyltransferases, to modulate the chromatin structure and regulate gene expression.
One of the key functions of FOXC1 is its involvement in embryonic development. It is expressed in various tissues during embryogenesis and is essential for the development of the eye, brain, heart, and other organs. Studies have shown that mutations in the FOXC1 gene can lead to developmental disorders, including glaucoma, congenital heart defects, and brain malformations.
In addition to its role in embryonic development, Recombinant Human FOXC1 Protein has also been implicated in various diseases and disorders. It has been found to be overexpressed in several types of cancer, including breast, lung, and colon cancer, and has been associated with tumor growth and metastasis. FOXC1 has also been linked to various ocular diseases, such as cataracts and glaucoma, as well as cardiovascular diseases, including atherosclerosis and hypertension.
Recombinant Human FOXC1 Protein has a wide range of applications in both basic research and clinical settings. Its ability to regulate gene expression makes it a valuable tool for studying the molecular mechanisms underlying various diseases and disorders. Researchers can use recombinant FOXC1 protein to study its role in embryonic development, cancer, and other diseases, and to identify potential therapeutic targets.
In addition, Recombinant Human FOXC1 Protein can also be used in drug discovery and development. By understanding how FOXC1 regulates gene expression, researchers can develop drugs that target this protein to treat diseases such as cancer and ocular disorders. Furthermore, recombinant FOXC1 protein can also be used in diagnostic tests for diseases associated with FOXC1 overexpression, such as certain types of cancer.
In conclusion, Recombinant Human FOXC1 Protein is a crucial protein that plays a significant role in regulating gene expression and is involved in various cellular processes. Its structure, activity, and applications make it a valuable tool for both basic research and clinical applications, and further studies on this protein may lead to new insights and treatments for various diseases and disorders.
ProteoGenix catalogue number ARO-P12060. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 22.04 kDa; Fragment: Ser82-Glu163; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
